Meet-the-Expert Sessions

• Discuss ways to optimise aerosol drug delivery across respiratory modalities
• Discuss the benefits of in-line aerosol therapy across respiratory modalities
• Present latest research in inhaled therapeutics

• Professor of critical care medicine.
• Intensive Care Unit of Tours University Hospital and Medical School, Tours University, Tours,
  France.
• Pharmacology of inhaled pharmaceuticals, Research Centre for Respiratory Disease. UMR 1100 – Institut National de la Santé et de la Recherche biomédicale (INSERM), Tours, France.

Ehrmann was trained as a critical care physician in Tours, France, and performed several parts of his training abroad: University of Heidelberg, Germany; Hospital Sant Pau Intensive Care Unit, Barcelona, Spain. He completed a PhD thesis in a laboratory focusing on respiratory and cell mechanics at the Paris-Est University, Paris, France. He focused his research on aerosol delivery to critically ill patients, performing large-scale observational studies and surveys on current practice, pharmacokinetic studies in animals and patients. Specifically, he developed in vitro, in vivo, and clinical research on aerosol delivery during nasal high flow therapy and coordinated one of the largest multicentre trials on prophylactic inhaled antibiotic therapy in intubated patients. He also coordinated international consensus work on aerosol therapy in critically ill patients.

Ehrmann ran several large-scale clinical trials in the field of respiratory critical care, evaluating fasting prior to extubation, awake prone positioning among non-intubated patients, developing innovative devices for communication with intubated patients, and performing research in the fields of acute kidney injury and hemodynamic management of critically ill patients. Ehrmann currently authored over 200 referenced scientific publications, gave over 100 invited national and international conferences, and his H-index is 50. He served as President of the French college of critical care scholars, chair of the epidemiology and research commission, and member of the scientific commission of the French Intensive Care Society. He completed two terms as a board member of the International Society for Aerosols in Medicine and chaired its networking group on new devices and emerging therapies. He also acted as a full-time advisor to the general directorate of healthcare provision of the French Ministry of Health during the two pandemic years.

Currently, Ehrmann is head of the Intensive Care Unit of Tours University Hospital, as well as President of the delegation for clinical research and innovation of the Centre Val de Loire region in France, Head of the technological innovation section of the clinical innovation center of Tours University Hospital, and co-coordinator of the International Clinical Research Network Crics-triggersep.